Skip to main content
. 2019 Jan 4;49(4):339–346. doi: 10.1093/jjco/hyy189

Figure 4.

Figure 4.

Change in incidence of skin toxicities and hypomagnesemia (CTCAE Grade 1≤), which are known as cetuximab-related adverse reactions.